These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11509057)

  • 1. Use of nonprescription weight loss products: results from a multistate survey.
    Blanck HM; Khan LK; Serdula MK
    JAMA; 2001 Aug 22-29; 286(8):930-5. PubMed ID: 11509057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity.
    Greenway F; Herber D; Raum W; Herber D; Morales S
    Obes Res; 1999 Jul; 7(4):370-8. PubMed ID: 10440593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The continuing epidemics of obesity and diabetes in the United States.
    Mokdad AH; Bowman BA; Ford ES; Vinicor F; Marks JS; Koplan JP
    JAMA; 2001 Sep; 286(10):1195-200. PubMed ID: 11559264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription weight loss pill use among Americans: patterns of pill use and lessons learned from the fen-phen market withdrawal.
    Blanck HM; Khan LK; Serdula MK
    Prev Med; 2004 Dec; 39(6):1243-8. PubMed ID: 15539063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of nonprescription dietary supplements for weight loss is common among Americans.
    Blanck HM; Serdula MK; Gillespie C; Galuska DA; Sharpe PA; Conway JM; Khan LK; Ainsworth BE
    J Am Diet Assoc; 2007 Mar; 107(3):441-7. PubMed ID: 17324663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey.
    Kaufman DW; Kelly JP; Rosenberg L; Anderson TE; Mitchell AA
    JAMA; 2002 Jan; 287(3):337-44. PubMed ID: 11790213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of self-prescribed nonprescription medications and dietary supplements among assisted living facility residents.
    Lam A; Bradley G
    J Am Pharm Assoc (2003); 2006; 46(5):574-81. PubMed ID: 17036643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of selected risk behaviors and chronic diseases--Behavioral Risk Factor Surveillance System (BRFSS), 39 steps communities, United States, 2005.
    Ramsey F; Ussery-Hall A; Garcia D; McDonald G; Easton A; Kambon M; Balluz L; Garvin W; Vigeant J;
    MMWR Surveill Summ; 2008 Oct; 57(11):1-20. PubMed ID: 18971922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health risks, past usage, and intention to use weight loss products in normal weight women with high and low body dysphoria.
    Whisenhunt BL; Williamson DA; Netemeyer RG; Andrews C
    Eat Weight Disord; 2003 Jun; 8(2):114-23. PubMed ID: 12880188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States.
    Qato DM; Alexander GC; Conti RM; Johnson M; Schumm P; Lindau ST
    JAMA; 2008 Dec; 300(24):2867-78. PubMed ID: 19109115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical studies with phenylpropanolamine: a metaanalysis.
    Greenway FL
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):203S-205S. PubMed ID: 1530830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylpropanolamine and stroke: the study, the FDA ruling, the implications.
    Mersfelder TL
    Cleve Clin J Med; 2001 Mar; 68(3):208-9, 213-9, 223. PubMed ID: 11263849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of selected risk behaviors and chronic diseases and conditions-steps communities, United States, 2006-2007.
    Cory S; Ussery-Hall A; Griffin-Blake S; Easton A; Vigeant J; Balluz L; Garvin W; Greenlund K;
    MMWR Surveill Summ; 2010 Sep; 59(8):1-37. PubMed ID: 20864923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of nonprescription medications for perceived cardiovascular health.
    Artz MB; Harnack LJ; Duval SJ; Armstrong C; Arnett DK; Luepker RV
    Am J Prev Med; 2006 Jan; 30(1):78-81. PubMed ID: 16414428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight control practices in adults: results of a multistate telephone survey.
    Serdula MK; Williamson DF; Anda RF; Levy A; Heaton A; Byers T
    Am J Public Health; 1994 Nov; 84(11):1821-4. PubMed ID: 7977925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylpropanolamine-associated hypertension after the use of "over-the-counter" appetite-suppressant products.
    McEwen J
    Med J Aust; 1983 Jul; 2(2):71-3. PubMed ID: 6679050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of obesity in the National Health and Nutrition Examination Survey (NHANES), 2007-2008.
    Samaranayake NR; Ong KL; Leung RY; Cheung BM
    Ann Epidemiol; 2012 May; 22(5):349-53. PubMed ID: 22305325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with potential medication-herb/natural product interactions in a rural community.
    Blalock SJ; Gregory PJ; Patel RA; Norton LL; Callahan LF; Jordan JM
    Altern Ther Health Med; 2009; 15(5):26-34. PubMed ID: 19771928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of dietary supplements for weight loss in the United States: results of a national survey.
    Pillitteri JL; Shiffman S; Rohay JM; Harkins AM; Burton SL; Wadden TA
    Obesity (Silver Spring); 2008 Apr; 16(4):790-6. PubMed ID: 18239570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attempting to lose weight: specific practices among U.S. adults.
    Kruger J; Galuska DA; Serdula MK; Jones DA
    Am J Prev Med; 2004 Jun; 26(5):402-6. PubMed ID: 15165656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.